Es gab 50 kürzliche Insider-Transaktionen für NanoVibronix, Inc. (NAOV), darunter 39 Käufe und 9 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.47M und die gesamten Insider-Verkäufe auf $856.46K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Brown Stephen Russell, Mika Thomas, Fashek Christopher M. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NAOV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-12-30 |
Brown Stephen Russell |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$0.60 |
$29.98K |
50,000 |
| 2024-12-30 |
Mika Thomas |
Director |
RSU-Zuteilung |
20,000 |
$0.60 |
$11.99K |
20,000 |
| 2024-12-30 |
Fashek Christopher M |
Director |
RSU-Zuteilung |
50,000 |
$0.60 |
$29.98K |
50,000 |
| 2024-12-30 |
Jacob Harold |
Chief Medical Officer |
RSU-Zuteilung |
10,000 |
$0.60 |
$6K |
10,000 |
| 2024-12-30 |
Ferguson Michael |
Director |
RSU-Zuteilung |
20,000 |
$0.60 |
$11.99K |
20,000 |
| 2024-12-30 |
Goldstein Martin M |
Director |
RSU-Zuteilung |
23,000 |
$0.60 |
$13.79K |
23,000 |
| 2024-12-30 |
Cassirer Aurora |
Director |
RSU-Zuteilung |
20,000 |
$0.60 |
$11.99K |
20,000 |
| 2024-12-30 |
Schroeder Maria |
Director |
RSU-Zuteilung |
20,000 |
$0.60 |
$11.99K |
20,000 |
| 2024-12-30 |
Murphy Brian M |
Chief Executive Officer |
RSU-Zuteilung |
80,000 |
$0.60 |
$47.96K |
80,000 |
| 2024-01-23 |
Ferguson Michael |
Director |
RSU-Zuteilung |
16,666 |
$0.90 |
$15K |
16,666 |
| 2024-01-23 |
Goldstein Martin M |
Director |
RSU-Zuteilung |
16,667 |
$0.90 |
$15K |
16,667 |
| 2024-01-23 |
Cassirer Aurora |
Director |
RSU-Zuteilung |
16,667 |
$0.90 |
$15K |
16,667 |
| 2024-01-23 |
Schroeder Maria |
Director |
RSU-Zuteilung |
16,667 |
$0.90 |
$15K |
16,667 |
| 2024-01-23 |
Mika Thomas |
Director |
RSU-Zuteilung |
16,666 |
$0.90 |
$15K |
16,666 |
| 2024-01-23 |
Jacob Harold |
Chief Medical Officer |
RSU-Zuteilung |
6,667 |
$0.90 |
$6K |
6,667 |
| 2023-11-29 |
Brown Stephen Russell |
Chief Financial Officer |
Aktienrückgabe |
2,500 |
$14.40 |
$36K |
- |
| 2023-11-29 |
Mika Thomas |
Director |
Aktienrückgabe |
3,000 |
$20.20 |
$60.6K |
- |
| 2023-11-29 |
Jacob Harold |
Chief Medical Officer |
Aktienrückgabe |
2,500 |
$20.20 |
$50.5K |
- |
| 2023-11-29 |
Ferguson Michael |
Director |
Aktienrückgabe |
2,875 |
$8.94 |
$25.7K |
- |
| 2023-11-29 |
Goldstein Martin M |
Director |
Aktienrückgabe |
4,575 |
$51.40 |
$235.16K |
- |
| 2023-11-29 |
Cassirer Aurora |
Director |
Aktienrückgabe |
2,500 |
$8.94 |
$22.35K |
- |
| 2023-11-29 |
Schroeder Maria |
Director |
Aktienrückgabe |
2,500 |
$8.94 |
$22.35K |
- |
| 2023-11-29 |
Fashek Christopher M |
Director |
Aktienrückgabe |
6,000 |
$16.80 |
$100.8K |
- |
| 2023-11-29 |
Murphy Brian M |
Chief Executive Officer |
Aktienrückgabe |
15,000 |
$20.20 |
$303K |
- |
| 2023-11-15 |
Brown Stephen Russell |
Chief Financial Officer |
RSU-Zuteilung |
14,000 |
$1.24 |
$17.36K |
14,000 |
| 2023-11-15 |
Mika Thomas |
Director |
RSU-Zuteilung |
3,334 |
$1.24 |
$4.13K |
3,334 |
| 2023-11-15 |
Jacob Harold |
Chief Medical Officer |
RSU-Zuteilung |
3,333 |
$1.24 |
$4.13K |
3,333 |
| 2023-11-15 |
Ferguson Michael |
Director |
RSU-Zuteilung |
3,334 |
$1.24 |
$4.13K |
3,334 |
| 2023-11-15 |
Goldstein Martin M |
Director |
RSU-Zuteilung |
3,333 |
$1.24 |
$4.13K |
3,333 |
| 2023-11-15 |
Cassirer Aurora |
Director |
RSU-Zuteilung |
3,333 |
$1.24 |
$4.13K |
3,333 |
| 2023-11-15 |
Schroeder Maria |
Director |
RSU-Zuteilung |
3,333 |
$1.24 |
$4.13K |
3,333 |
| 2023-11-15 |
Fashek Christopher M |
Director |
RSU-Zuteilung |
14,000 |
$1.24 |
$17.36K |
14,000 |
| 2023-11-15 |
Murphy Brian M |
Chief Executive Officer |
RSU-Zuteilung |
20,000 |
$1.24 |
$24.8K |
20,000 |
| 2023-01-05 |
Mika Thomas |
Director |
Informierter Kauf |
50,000 |
$0.25 |
$12.5K |
50,000 |
| 2022-06-15 |
Fashek Christopher M |
Director |
Informierter Kauf |
40,000 |
$0.60 |
$23.83K |
75,000 |
| 2022-06-14 |
Brown Stephen Russell |
Chief Financial Officer |
Informierter Kauf |
4,000 |
$0.57 |
$2.3K |
4,000 |
| 2022-06-01 |
Cassirer Aurora |
Director |
Informierter Kauf |
2,000 |
$0.69 |
$1.38K |
2,000 |
| 2022-01-13 |
Cassirer Aurora |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-01-13 |
Schroeder Maria |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-12-29 |
Mika Thomas |
Director |
RSU-Zuteilung |
60,000 |
$1.01 |
$60.6K |
60,000 |
| 2021-12-29 |
Fashek Christopher M |
Director |
RSU-Zuteilung |
80,000 |
$1.01 |
$80.8K |
80,000 |
| 2021-12-29 |
Jacob Harold |
Chief Medical Officer |
RSU-Zuteilung |
50,000 |
$1.01 |
$50.5K |
50,000 |
| 2021-12-29 |
Murphy Brian M |
Chief Executive Officer |
RSU-Zuteilung |
300,000 |
$1.01 |
$303K |
300,000 |
| 2021-12-29 |
Brown Stephen Russell |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
$1.01 |
$101K |
100,000 |
| 2021-12-29 |
Ferguson Michael |
Director |
RSU-Zuteilung |
57,500 |
$1.01 |
$58.08K |
57,500 |
| 2021-12-29 |
Goldstein Martin M |
Director |
RSU-Zuteilung |
50,000 |
$1.01 |
$50.5K |
50,000 |
| 2020-12-22 |
Brown Stephen Russell |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$0.84 |
$42K |
50,000 |
| 2020-12-22 |
Mika Thomas |
Director |
RSU-Zuteilung |
90,000 |
$0.84 |
$75.6K |
90,000 |
| 2020-12-22 |
Fashek Christopher M |
Director |
RSU-Zuteilung |
120,000 |
$0.84 |
$100.8K |
120,000 |
| 2020-12-22 |
Murphy Brian M |
Chief Executive Officer |
RSU-Zuteilung |
200,000 |
$0.84 |
$168K |
200,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
